IL-7 promotes T(H)1 development and serum IL-7 predicts clinical response to interferon-β in multiple sclerosis.

PubWeight™: 1.73‹?› | Rank: Top 3%

🔗 View Article (PMC 3739690)

Published in Sci Transl Med on July 27, 2011

Authors

Li-Fen Lee1, Robert Axtell2, Guang Huan Tu1, Kathryn Logronio1, Jeanette Dilley1, Jessica Yu1, Mathias Rickert1, Bora Han3, Winston Evering3, Michael G Walker4, Jing Shi4, Brigit A de Jong5, Joep Killestein6, Chris H Polman6, Lawrence Steinman2, John C Lin1

Author Affiliations

1: Rinat, Pfizer Inc., South San Francisco, USA.
2: Department of Neurology and Neurological Sciences, Stanford University, Stanford, California, USA.
3: Drug Safety R&D, Pfizer Inc., La Jolla, USA.
4: Walker Bioscience, Carlsbad, CA 92009, USA.
5: Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
6: VU University Medical Center, Amsterdam, The Netherlands.

Articles citing this

Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MS. Neurology (2012) 1.76

Anti-IL-7 receptor-α reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function. Proc Natl Acad Sci U S A (2012) 1.60

IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells. Proc Natl Acad Sci U S A (2012) 1.54

Interleukin-7 enhances the Th1 response to promote the development of Sjögren's syndrome-like autoimmune exocrinopathy in mice. Arthritis Rheum (2013) 1.53

Genetic variants associated with autoimmunity drive NFκB signaling and responses to inflammatory stimuli. Sci Transl Med (2015) 1.46

Optimization of current and future therapy for autoimmune diseases. Nat Med (2012) 1.29

STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammation. Cell Res (2014) 1.15

Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity. Proc Natl Acad Sci U S A (2013) 1.07

Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients. Neurol Neuroimmunol Neuroinflamm (2016) 0.98

Early IL-17 production by intrahepatic T cells is important for adaptive immune responses in viral hepatitis. J Immunol (2012) 0.95

Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future. Expert Rev Clin Immunol (2014) 0.94

Crucial roles of interleukin-7 in the development of T follicular helper cells and in the induction of humoral immunity. J Virol (2014) 0.91

Mechanistic biomarkers for clinical decision making in rheumatic diseases. Nat Rev Rheumatol (2013) 0.88

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis. J Neuroinflammation (2012) 0.87

Janus-like effects of type I interferon in autoimmune diseases. Immunol Rev (2012) 0.86

Innate immune signaling induces interleukin-7 production from salivary gland cells and accelerates the development of primary Sjögren's syndrome in a mouse model. PLoS One (2013) 0.85

IL7Rα contributes to experimental autoimmune encephalomyelitis through altered T cell responses and nonhematopoietic cell lineages. J Immunol (2013) 0.84

VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitis. Cell Mol Neurobiol (2014) 0.83

Identification of shared genes and pathways: a comparative study of multiple sclerosis susceptibility, severity and response to interferon beta treatment. PLoS One (2013) 0.83

Repeated exposure to Lutzomyia intermedia sand fly saliva induces local expression of interferon-inducible genes both at the site of injection in mice and in human blood. PLoS Negl Trop Dis (2014) 0.83

Reassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosis. PLoS One (2011) 0.83

Systemic administration of TLR3 agonist induces IL-7 expression and IL-7-dependent CXCR3 ligand production in the lung. J Leukoc Biol (2012) 0.81

Perspectives of the relationship between IL-7 and autoimmune diseases. Clin Rheumatol (2013) 0.80

Opposing effects of CTLA4 insufficiency on regulatory versus conventional T cells in autoimmunity converge on effector memory in target tissue. J Immunol (2014) 0.78

Variants of Interleukin-7/Interleukin-7 Receptor Alpha are Associated with Both Neuromyelitis Optica and Multiple Sclerosis Among Chinese Han Population in Southeastern China. Chin Med J (Engl) (2015) 0.77

Cellular immune responses in multiple sclerosis patients treated with interferon-beta. Clin Exp Immunol (2013) 0.77

Translational utility of experimental autoimmune encephalomyelitis: recent developments. J Inflamm Res (2015) 0.76

Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer. Mol Ther (2017) 0.76

Modulation of peripheral T-cell function by interleukin-7 in rheumatoid arthritis. Arthritis Res Ther (2014) 0.76

Interleukin-7 is required for CD4(+) T cell activation and autoimmune neuroinflammation. Clin Immunol (2015) 0.76

Innate Immune Signaling Induces IL-7 Production, Early Inflammatory Responses, and Sjögren's-Like Dacryoadenitis in C57BL/6 Mice. Invest Ophthalmol Vis Sci (2015) 0.76

A gene network regulated by the transcription factor VGLL3 as a promoter of sex-biased autoimmune diseases. Nat Immunol (2016) 0.75

Genetic association of rs1520333 G/A polymorphism in the IL7 gene with multiple sclerosis susceptibility in Isfahan population. Adv Biomed Res (2014) 0.75

Regulation of effector function of CNS autoreactive CD4 T cells through inhibitory receptors and IL-7Rα. J Neuroinflammation (2016) 0.75

Administration of Myelin Basic Protein Peptides Encapsulated in Mannosylated Liposomes Normalizes Level of Serum TNF-α and IL-2 and Chemoattractants CCL2 and CCL4 in Multiple Sclerosis Patients. Mediators Inflamm (2016) 0.75

IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis. J Immunol (2015) 0.75

Safety profiles come to fore as more drugs approach MS market. Nat Biotechnol (2012) 0.75

IL-7 induces clathrin-mediated endocytosis of CD127 and subsequent degradation by the proteasome in primary human CD8 T cells. Immunol Cell Biol (2015) 0.75

Ginger extract modulates the expression of IL-12 and TGF-β in the central nervous system and serum of mice with experimental autoimmune encephalomyelitis. Avicenna J Phytomed (2017) 0.75

Articles cited by this

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature (2006) 46.36

Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell (2009) 20.29

ROCR: visualizing classifier performance in R. Bioinformatics (2005) 19.60

Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med (2007) 17.06

Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe (2008) 11.08

The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol (2008) 9.64

Immunology of multiple sclerosis. Annu Rev Immunol (2005) 9.08

Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med (1994) 8.97

Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med (1995) 7.52

Homeostasis of naive and memory T cells. Immunity (2008) 7.48

Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med (2002) 7.11

IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci U S A (2001) 6.91

Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet (2007) 5.09

Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol (2007) 4.87

T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat Med (2010) 4.78

Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet (1998) 4.32

Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet (2007) 4.22

Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat Immunol (2003) 3.82

Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor. J Exp Med (2000) 3.51

The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J Immunol (2005) 3.51

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain (2003) 3.39

Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. J Immunol (2001) 2.69

Retracted Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease. Nat Med (2010) 2.43

Cell biology of IL-7, a key lymphotrophin. Cytokine Growth Factor Rev (2005) 2.35

Coordinate analysis of murine immune cell surface markers and intracellular phosphoproteins by flow cytometry. J Immunol (2005) 1.93

The common gamma chain (gamma c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3. Biochemistry (2002) 1.68

Characterization of the murine immunological signaling network with phosphospecific flow cytometry. J Immunol (2005) 1.65

Role of the common cytokine receptor gamma chain in cytokine signaling and lymphoid development. Immunol Rev (1995) 1.61

Modulation of immune homeostasis by commensal bacteria. Curr Opin Microbiol (2011) 1.57

TSLP: finally in the limelight. Nat Immunol (2002) 1.47

Segmented filamentous bacteria take the stage. Mucosal Immunol (2010) 1.37

Interleukin-7 receptor signaling network: an integrated systems perspective. Cell Mol Immunol (2008) 1.22

Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators. Arthritis Rheum (2010) 1.17

Class II major histocompatibility complex-peptide tetramer staining in relation to functional avidity and T cell receptor diversity in the mouse CD4(+) T cell response to a rheumatoid arthritis-associated antigen. Arthritis Rheum (2005) 1.14

Preferential expansion of autoreactive T lymphocytes from the memory T-cell pool by IL-7. J Neuroimmunol (1999) 1.02

IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis. Genes Immun (2010) 0.97

Interleukin 7 receptor alpha chain haplotypes vary in their influence on multiple sclerosis susceptibility and response to interferon Beta. J Interferon Cytokine Res (2010) 0.84